IN2013MU02986A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02986A
IN2013MU02986A IN2986MU2013A IN2013MU02986A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A IN 2986MU2013 A IN2986MU2013 A IN 2986MU2013A IN 2013MU02986 A IN2013MU02986 A IN 2013MU02986A
Authority
IN
India
Prior art keywords
agents
group
sodium
gum
sterculiafoetida
Prior art date
Application number
Inventor
Vijay Deorao Dr Gulkari
Rahul Harishchandra Dr Kasliwal
Shashikant Sadashivrao Burpute
Shailendra Shivaji Dr Gurav
Gurav Nilambari Shailendra Mrs
Original Assignee
Vijay Deorao Dr Gulkari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vijay Deorao Dr Gulkari filed Critical Vijay Deorao Dr Gulkari
Priority to IN2986MU2013 priority Critical patent/IN2013MU02986A/en
Publication of IN2013MU02986A publication Critical patent/IN2013MU02986A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention provides an orally administrable gastro retentive dosage form comprising at least one pharmaceutically active ingredient; a combination of Sterculiafoetida gum and xanthan gum as polymer in a ratio of 0.5:1 to 3:l;at least one gas generating agent selected from the group consisting of sodium carbonate, sodium bicarbonate, sodium metabisulfite, calcium carbonate and mixtures thereof; and at least one excipient selected from the group consisting of binders, diluents, disintegrants, lubricating agents, -wetting agents, polymers, surfactants, sweeteners, flavours, pH adjusting agents, glidents, coating agents, plasticizers and colorants.
IN2986MU2013 2013-09-13 2013-09-13 IN2013MU02986A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2986MU2013 IN2013MU02986A (en) 2013-09-13 2013-09-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2986MU2013 IN2013MU02986A (en) 2013-09-13 2013-09-13

Publications (1)

Publication Number Publication Date
IN2013MU02986A true IN2013MU02986A (en) 2015-10-09

Family

ID=54397044

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2986MU2013 IN2013MU02986A (en) 2013-09-13 2013-09-13

Country Status (1)

Country Link
IN (1) IN2013MU02986A (en)

Similar Documents

Publication Publication Date Title
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EA201690962A1 (en) COMPOSITIONS
PH12015501993B1 (en) Pyrazole-amide compound and medicinal uses therefor
MX2016006053A (en) Selective pyy compounds and uses thereof.
TN2011000172A1 (en) Therapeutic antiviral peptides
PT2310356E (en) Adamantyl diamide derivatives and uses of same
MY183312A (en) Pharmaceutical formulation
MY187718A (en) Pharmaceutical formulations
MX343689B (en) Darunavir combination formulations.
JOP20190233A1 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
TN2015000135A1 (en) Modified release formulations for oprozomib
MX341976B (en) Darunavir formulations.
MD3482754T2 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
MY174005A (en) Swallowable n-acetylcysteine tablets
EA201791009A1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
EA202090542A1 (en) HIGHLY CONCENTRATED MEDICINAL FORMS OF Pridopidine
EA201490166A1 (en) Fluorinated arylalkyl-aminocarboxamide derivatives
JO3192B1 (en) Benzothiazolone compound
NZ701103A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
BR112017019364A2 (en) solid dispersions
IN2013MU02986A (en)
MX2020007326A (en) Dosing regimen of siponimod.
IN2013MU02985A (en)
TN2015000156A1 (en) Dispersible tablet
EA201500368A1 (en) PHARMACEUTICAL COMPOSITION OF 1-ADAMANTYLETHYLOXY-3-MORFOLIN-2-PROPANOL OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR TREATING CARDIOVASCULAR PATHOLOGY